Stock analysis, price data, and AI-powered insights for Centene Corporation (CNC).
Centene Corporation operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for CNC.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). CNC Stock Intelligence Report. [stoxpulse.com/stocks/cnc]
Disclaimer: The information on this page about Centene Corporation (CNC) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Centene Corporation.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings beat by 129%
Jun 30
DIAZ bought 3K shares
3d ago
Tyler bought 3K shares
Jul 17
Top Stock Reports for Applied Materials, Sandisk &...
5h ago
CI Q2 Earnings Beat Estimates on Cigna Healthcare ...
8h ago
StoxPulse AI results for CNC: Pulse Score 46/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$30.05B
P/E Ratio
-4.5
EPS
$2.19
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Sep 25
+454.9%
Dec 25
+3.7%
Mar 26
+56.4%
Jun 26
+129.0%
Beat estimates 4 of 4 quarters (100%)
Sector
Healthcare
Industry
Managed Health Care
Top Stock Reports for Applied Materials, Sandisk & Eaton
CI Q2 Earnings Beat Estimates on Cigna Healthcare Strength
Best Momentum Stock to Buy for July 30th
Should Value Investors Buy Centene (CNC) Stock?
Centene (CNC) Could Be 3% Undervalued After Strong Q2 Earnings And Higher Outlook
Centene (CNC) Stock Still Looks Like A Bargain As Its 150% Run Continues
UnitedHealth's Cost-Control Story is Gaining Momentum: Time to Buy?
Centene's Strong Q2 Beat Overshadowed by Delayed Medicaid Margin Recovery, RBC Says